Evidence map›Paper›PMID 29321951›Full record

ArticleChemistryOpen2018

Utility of the Phenacyl Protecting Group in Traceless Protein Semisynthesis through Ligation-Desulfurization Chemistry.

Maria Matveenko, Stefanie Hackl, Christian F W Becker

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.Journal of peptide science : an official publication of the European Peptide Society · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Maria MatveenkoInstitute of Biological Chemistry, Faculty of Chemistry University of Vienna Währinger Str. 38 1090 Vienna Austria.ORCID 0000-0002-3797-7355
Stefanie HacklInstitute of Biological Chemistry, Faculty of Chemistry University of Vienna Währinger Str. 38 1090 Vienna Austria.
Christian F W BeckerInstitute of Biological Chemistry, Faculty of Chemistry University of Vienna Währinger Str. 38 1090 Vienna Austria.ORCID 0000-0002-8890-7082
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Semisynthesis of proteins via expressed protein ligation is a widely applicable method, even more so because of the possibility of ligation at non-cysteine sites using β-mercapto amino acids that can be converted to the corresponding native amino acids by desulfurization. A drawback of this ligation- desulfurization approach is the removal of any unprotected native cysteine residues within the ligated protein segments. Here, we show that the phenacyl (PAc) moiety can be successfully used to protect cysteines within recombinantly generated protein segments. As such, this group was selectively appended onto cysteine side chains within bacterially expressed polypeptides following intein cleavage, which reveals a rather sensitive thioester at the C-terminus. The PAc group proved to be compatible with native chemical ligation, radical desulfurization, and reverse-phase HPLC conditions, and was smoothly removed at the end. The utility of the PAc protecting group was then demonstrated by the 'traceless' semisynthesis of two proteins containing one or two native cysteines: human small heat shock protein Hsp27 and murine prion protein.

Indexed as

cysteineligation–desulfurizationprotecting groupsprotein modificationsprotein semisynthesis

Identifiers

PMID29321951
PMCPMC5759462
OpenAlexW2790527622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.